Proton pump inhibitor vs histamine 2 receptor antagonists for prophylaxis of stress ulcer in critically ill patients
Keywords:
stress ulcer, famotidine, omeprazoleAbstract
Introduction: stress ulcer is one of the serious complications in critically ill patients admitted to intensive care unit and associated with increase in mortality rate among them, proton pump inhibitor and histamine 2 receptor antagonist have been widely used as stress ulcer prophylaxis (SUP) in critically ill patients, however its efficacy and safety remain unclear. This study aimed to assess the efficacy of SUP on clinical outcomes in critically ill patients. Aim of study: To compare between proton pump inhibitors and histamine 2 receptor antagonists in prevention of stress ulcer. Material and method: We do a single, blind, randomized trial on two hundred critically ill patients admitted to intensive care unit divided into two groups, group A took famotidine 40mg single daily enterally and group B took omeprazole 40mg single daily intravenously. Results: Statistically there is no difference in incidence of stress ulcer among the two group of patients with P value of 0.25. Conclusion: The use of histamine 2 receptor antagonist is equal to proton pump inhibitor in prevention of stress ulcer and associated with less side effect than proton pump inhibitor
Downloads
References
"Omeprazole". The American Society of Health-System Pharmacists. Retrieved 21 October 2018
A Practical Approach to Emergency Medicine by Robert J. Stine, M.D., Carl R. Chudnofsky, M.D., Cynthia K. Aaron, M.D. (1994)
Abou Chakra CN, Pepin J, Sirard S, Valiquette L. Risk factors for recurrence, complications and mortality in Clostridium difficile infection: a systematic review [published correction appears in PLoS One. 2014;9(8):e107420]. PLoS One. 2014;9(6):e98400. Published 2014 Jun 4. doi:10.1371/journal.pone.0098400
Alhazzani W, Alshamsi F, Belley-Cote E, et al. Efficacy and safety of stress ulcer prophylaxis in critically ill patients: a network meta-analysis of randomized trials [published correction appears in Intensive Care Med. 2017 Dec[11;:]. Intensive Care Med. 2018;44(1):1-11. doi:10.1007/s00134-017-5005
Alhazzani, Waleed MD1; Alenezi, Farhan MD1; Jaeschke, Roman Z. MD1,2; Moayyedi, Paul MD1,2; Cook, Deborah J. MD1,2 Proton Pump Inhibitors Versus Histamine 2 Receptor Antagonists for Stress Ulcer Prophylaxis in Critically Ill Patients, Critical Care Medicine: March 2013 - Volume 41 - Issue 3 - p 693-705 doi: 10.1097/CCM.0b013e3182758734
Bailey & Love’s SHORT PRACTICE OF SURGERY 23rd Edition, page 916
Cook DJ, Fuller HD, Guyatt GH, Marshall JC, Leasa D, Hall R, Winton TL, Rutledge F, Todd TJ, Roy P, et al. Risk factors for gastrointestinal bleeding in critically ill patients. Canadian Critical Care Trials Group. N Engl J Med. 1994 Feb 10;330(6):377-81. doi: 10.1056/NEJM199402103300601. PMID: 8284001. Hai, A.A. & Shrivastava, R.B. (2003). Textbook of Surgery. Tata/McGraw-Hill. ISBN 0074621491, page 409
Fujiwara Y, Higuchi K, Nebiki H, Chono S, Uno H, Kitada K, Satoh H, Nakagawa K, Kobayashi K, Tominaga K, Watanabe T, Oshitani N, Arakawa T. Famotidine vs. omeprazole: a prospective randomized multicentre trial to determine efficacy in non-erosive gastro-oesophageal reflux disease. Aliment Pharmacol Ther. 2005 Jun;21 Suppl 2:10-8.
Kantorova I, Svoboda P, Scheer P, Doubek J, Rehorkova D, Bosakova H, Ochmann J. Stress ulcer prophylaxis in critically ill patients: a randomized controlled trial. Hepatogastroenterology. 2004 May-Jun;51(57):757-61. PMID: 15143910.
Manual of Gastroenterology by Gregory L. Eastwood, M.D. &Canan Avunduk, M.D., Ph.D. (2008)
Manual of Gastroenterology priyank sinha Gregory L. Eastwood, M.D. & Canan Avunduk, M.D., Ph.D. (2009)
Manual of Gastroenterology: Diagnosis and Therapy by Gregory L. Eastwood, M.D. &Canan Avunduk, M.D., Ph.D. (2008). page167
Marik, Paul E. MD; Vasu, Tajender MD; Hirani, Amyn MD; Pachinburavan, Monvasi MD Stress ulcer prophylaxis in the new millennium: A systematic review and meta-analysis, Critical Care Medicine: November 2010 - Volume 38 - Issue 11 - p 2222-2228
Naufal, M. A., & Pathak, V. N. (2022). Stress, emotional intelligence and self-esteem among college students during 2nd wave COVID-19. International Journal of Health Sciences, 6(S3), 5050–5058. https://doi.org/10.53730/ijhs.v6nS3.7007
Plummer MP, Blaser AR, Deane AM. Stress ulceration: prevalence, pathology and association with adverse outcomes. Crit Care. 2014;18(2):213. Published 2014 Mar 18. doi:10.1186/cc13780
Ratnawati, I. G. A. A., Suandayani, N. K. T., & Sutapa, G. N. (2019). The linearity of x-ray devices radiation output and its relationship with patient thickness. International Journal of Physical Sciences and Engineering, 3(3), 1–6. https://doi.org/10.29332/ijpse.v3n3.351
Song, M.J., Kim, S., Boo, D. et al. Comparison of proton pump inhibitors and histamine 2 receptor antagonists for stress ulcer prophylaxis in the intensive care unit. Sci Rep 11, 18467 (2021). https://doi.org/10.1038/s41598-021-98069-7
Suryasa, I. W., Rodríguez-Gámez, M., & Koldoris, T. (2021). Health and treatment of diabetes mellitus. International Journal of Health Sciences, 5(1), i-v. https://doi.org/10.53730/ijhs.v5n1.2864
Published
How to Cite
Issue
Section
Copyright (c) 2022 International journal of health sciences
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
Articles published in the International Journal of Health Sciences (IJHS) are available under Creative Commons Attribution Non-Commercial No Derivatives Licence (CC BY-NC-ND 4.0). Authors retain copyright in their work and grant IJHS right of first publication under CC BY-NC-ND 4.0. Users have the right to read, download, copy, distribute, print, search, or link to the full texts of articles in this journal, and to use them for any other lawful purpose.
Articles published in IJHS can be copied, communicated and shared in their published form for non-commercial purposes provided full attribution is given to the author and the journal. Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgment of its initial publication in this journal.
This copyright notice applies to articles published in IJHS volumes 4 onwards. Please read about the copyright notices for previous volumes under Journal History.
